HAE Financial Facts

Research, development and engineering: 8.34M
Selling, general and administrative: 71.12M
See Full Income Statement

Inventories, net: 194.51M
Total stockholders' equity: 749.11M
See Full Balance Sheet

Haemonetics Corp. (HAE) Earnings

  |   Expand Research on HAE
Next EPS Date 8/4/21 *Est. EPS Growth Rate -33.3% *Last Qtr.
Average EPS % Beat Rate +6.3% Revenue Growth Rate -5.5% *Last Qtr.
Average % Move 1-Wk after EPS +3.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/13/21 Q421 $0.46$0.67 -$0.21$225M$222.98M = Details
2/2/21 Q321 $0.81$0.66 +$0.15$240M$225.73M N/A Details
11/4/20 Q221 $0.62$0.51 +$0.11$209M$207.65M N/A Details
8/4/20 Q121 $0.46$0.41 +$0.05$196M$198.27M N/A Details
5/5/20 Q420 $0.69$0.73 -$0.04$238M$247.15M N/A Details
2/4/20 Q320 $0.94$0.76 +$0.18$259M$255.4M = Details
11/1/19 Q220 $0.87$0.69 +$0.18$253M$249.77M = Details
8/6/19 Q120 $0.81$0.63 +$0.18$238M$237.72M = Details